EUVIMEDOdkrijte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

The Use of Deep Learning in RNA Therapeutic Development

Deepak A Subramanian iD, Sophia L Yao, Alvin Chan, Jacob Witten, Daniel Reker iD, Daniel G Anderson iD, Robert Langer iD, Giovanni Traverso iD

ACS Nano · 2026-06-23 · 20 (24) · 17163-17177

DOI: 10.1021/acsnano.6c02090 ↗

At a glance

Übersichtsarbeit in ACS Nano, published online on 2026-06-10. Written by Deepak A Subramanian and 7 co-authors. Institution: Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States. Major MEDLINE topics: Deep Learning, RNA, Genetic Therapy. Cited 1 times so far (Crossref); 183 references. The full text is freely available (open access, CC BY 4.0). Funded by: NHLBI NIH HHS, Cystic Fibrosis Foundation, Sanofi.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Ribonucleic acid (RNA)-based therapeutics have emerged as promising methods of disease treatment due to their ability to target the human genome and influence protein production, their versatility, and their relative lack of toxicity compared to other gene therapies. However, the RNA therapeutic design space is extremely large, encompassing multiple variables, including codon identities, secondary structure, and design of specific regions. RNA therapeutic optimization is difficult due to the impracticality of exploring such a vast design space experimentally. To address this limitation, deep learning methods have been employed to optimize RNA therapeutic development. In this review, we examine the application of deep learning models across three key aspects of RNA therapeutic development (RNA structure prediction, CRISPR activity, and RNA delivery), highlighting major contributions in these fields and analyzing how deep learning model architectures could affect model performance. We then discuss challenges associated with using deep learning for RNA therapeutics, such as computational and data limitations. Finally, we offer perspectives on areas for future exploration, such as emerging model architectures and methods of integration with more advanced high-throughput screening techniques. Ultimately, this review provides an overview of how deep learning is used in RNA therapeutic development and how it can evolve in the future.

Subjects

MeSH terms (MEDLINE)

Deep LearningRNAGenetic TherapyHumansNucleic Acid Conformation

Author keywords

RNAcomputational modelingdeep learningdeliverygene editinghigh-throughput screeningneural networkstructurevocabulary

Substances

RNA

Authors and institutions

  • Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
  • David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
  • Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
  • Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
  • College of Computing and Data Science, Nanyang Technological University, Singapore 639798, Singapore.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 639798, Singapore.

ORCID profiles: Deepak A Subramanian, Daniel Reker, Daniel G Anderson, Robert Langer, Giovanni Traverso

Funding

  • NHLBI NIH HHS
  • Cystic Fibrosis Foundation
  • Sanofi
  • Brigham and Women's Hospital
  • Duke University
  • Harvard Medical School
  • Massachusetts Institute of Technology
  • Advanced Research Projects Agency for Health

Cite

APA

Subramanian, D. A., Yao, S. L., Chan, A., Witten, J., Reker, D., Anderson, D. G., Langer, R., & Traverso, G. (2026). The Use of Deep Learning in RNA Therapeutic Development. ACS Nano, 20(24), 17163-17177. https://doi.org/10.1021/acsnano.6c02090

Vancouver

Subramanian DA, Yao SL, Chan A, Witten J, Reker D, Anderson DG, et al. The Use of Deep Learning in RNA Therapeutic Development. ACS Nano. 2026;20(24):17163-17177. doi:10.1021/acsnano.6c02090

BibTeX
@article{Subramanian2026,
  author = {Subramanian, Deepak A and Yao, Sophia L and Chan, Alvin and Witten, Jacob and Reker, Daniel and Anderson, Daniel G and Langer, Robert and Traverso, Giovanni},
  title = {The Use of Deep Learning in RNA Therapeutic Development},
  journal = {ACS Nano},
  year = {2026},
  volume = {20},
  number = {24},
  pages = {17163--17177},
  doi = {10.1021/acsnano.6c02090}
}
Start for free →